Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy
FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy
FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy
Submitted by
admin
on February 3, 2015 - 9:07am
Source:
Bidness Etc.
News Tags:
FDA
breakthrough therapies
Genentech
anti-PD-L1
MPDL3280A
non-small cell lung cancer
Headline:
FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy
Do Not Allow Advertisers to Use My Personal information
